E. Shefter

发表

DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS.

E. Shefter, T. Higuchi, 1963, Journal of pharmaceutical sciences.

The Development of USP Dissolution and Drug Release Standards

J. Robinson, C. Rhodes, E. Shefter, 1990, Pharmaceutical Research.

Out-of-plane deformations of cyclic polyenes

E. Shefter, H. Bürgi, 1975 .

Chemical reaction paths—VI : A pericyclic ring closure

J. Dunitz, E. Shefter, H. Bürgi, 1975 .

THE CRYSTAL AND MOLECULAR STRUCTURE OF D(+)-BARIUM URIDINE-5'-PHOSPHATE.

K. Trueblood, E. Shefter, 1965, Acta crystallographica.

Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach.

M. Hussain, E. Shefter, C. Koval, 1987, Journal of pharmaceutical sciences.

Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine.

C. Romming, D. Triggle, E. Shefter, 1982, Journal of medicinal chemistry.

Long chain arginine esters: a new class of cationic detergents for preparation of hydrophobic ion-paired complexes.

M. Manning, D. Kroll, D. J. Claffey, 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

A Kinetic Study of the Solid State Transformation of Sodium Bicarbonate to Sodium Carbonate

S. Ramalingam, E. Shefter, A. Lo, 1974 .

Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.

E. Shefter, B. Aungst, N. J. Rogers, 1988, The Journal of pharmacology and experimental therapeutics.

Chemical reaction paths. IV. Aspects of O⋯C = O interactions in crystals

J. Dunitz, E. Shefter, H. Bürgi, 1974 .

Improved Buccal Delivery of Opioid Analgesics and Antagonists with Bitterless Prodrugs

M. Hussain, E. Shefter, B. Aungst, 1988, Pharmaceutical Research.

Buccal and oral bioavailability of naloxone and naltrexone in rats

M. Hussain, E. Shefter, B. Aungst, 1987 .

Buccal and oral bioavailability of nalbuphine in rats.

M. Hussain, E. Shefter, B. Aungst, 1986, Journal of pharmaceutical sciences.

Enhanced solubility of proteins and peptides in nonpolar solvents through hydrophobic ion pairing

M. Manning, J. Matsuura, E. Shefter, 1993 .

In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease.

M. Manning, D. Malone, J. Matsuura, 1999, Drug development and industrial pharmacy.

Crystal and molecular structure of 6-thiopurine riboside.

E. Shefter, 1968, Journal of pharmaceutical sciences.

Crystal structure of 2,4-diselenouracil.

M. James, H. Mautner, E. Shefter, 1966, Journal of pharmaceutical sciences.

Crystal and molecular structure of 5-[1-(2′-deoxy-α-d-ribofuranosyl)uracilyl] disulfide

E. Shefter, T. Bardos, M. Kotick, 1967 .

Structure and stability of insulin dissolved in 1-octanol

M. Manning, J. Matsuura, E. Shefter, 1993 .

Antihypertensive Activity of 2[(2-Hydroxyphenyl) amino] -4(3H)-quinazolinone

M. Hussain, P. Timmermans, W. Price, 1988, Pharmaceutical Research.

Geometrical reaction coordinates. II. Nucleophilic addition to a carbonyl group

Jack D. Dunitz, Eli Shefter, J. Dunitz, 1973 .

Zn(II)-theophylline-ethylenediamine: structure and pH stability.

M. Gardner, E. Shefter, F. X. Smith, 1983, Journal of pharmaceutical sciences.

Structural studies on complexes. IV. Crystal structure of a 1:1 5-chlorosalicylic acid and theophylline complex.

E. Shefter, 1969, Journal of pharmaceutical sciences.

Isolation and identification of the cis-trans stereoisomers of substituted 3-hydroxy-(or acetoxy) 2-methyl-2,3-dihydrobenzofurans. Dihydrobenzofurans which obey the Karplus equation

E. Shefter, L. J. Powers, M. Mertes, 1971 .

Ring-D-bridged steroid analogs. VI. Proof of stereochemistry and further reactions of 14α, 17α-etheno-16α-carbomethoxypregn-5-ene-3β-ol-20-one acetate

Baldev Singh, E. Shefter, A. J. Solo, 1968 .

The Use of α-Aminoboronic Acid Derivatives to Stabilize Peptide Drugs During Their Intranasal Absorption

M. Hussain, E. Shefter, S. Rowe, 1989, Pharmaceutical Research.

Structural studies on complexes. II. Crystal and molecular structure of a 1:1 caffeine and 5-chlorosalicyclic acid complex.

E. Shefter, 1968, Journal of pharmaceutical sciences.

CRYSTAL STRUCTURES AND PHARMACOLOGICAL ACTIVITY OF CALCIUM CHANNEL ANTAGONISTS: 2,6‐DIMETHYL‐3,5‐DICARBOMETHOXY‐4‐(UNSUBSTITUTED, 3‐METHYL‐, 4‐METHYL‐ 3‐NITRO‐, 4‐NITRO‐, AND 2,4‐DINITROPHENYL)‐1,4‐DIHYDROPYRIDINE

C. Romming, D. Triggle, E. Shefter, 1982 .

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

A M Triggle, D J Triggle, A. M. Triggle, 1980, Journal of medicinal chemistry.

Pharmacological implications of the conformation of the methadone base.

J. Dunitz, E. Shefter, H. Bürgi, 1973, Nature: New biology.

Crystal Structure of a Complex of Acridine, Cytosine, and Water (1: 1 : 1)

E. Shefter, 1968, Science.

Crystal and Molecular Structure of Acetylselenocholine Iodide

E. Shefter, T. P. Singh, 1966, Science.

Dehydration of crystalline theophylline monohydrate and ampicillin trihydrate.

E. Shefter, H. Fung, O. Mok, 1973, Journal of pharmaceutical sciences.

Hydrolytic behavior of some aluminum antiperspirant materials in acid

E. Shefter, R. Giannini, 1978 .

Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides

E. Shefter, B. Aungst, N. J. Rogers, 1986 .

Crystal structure analysis of the desolvation of the chloroform solvate of griseofulvin

E. Shefter, K. Cheng, T. Srikrishnan, 1979 .

Crystal and Molecular Structure of 1,3-Dihydro-1-hydroxy-3-oxo-1,2-benziodoxole

W. Wolf, E. Shefter, 1964, Nature.

The correlation of the crystal and molecular structure with the nuclear magnetic resonance spectrum of a bicyclo[1.1.1]pentane derivative

A. Padwa, E. Shefter, E. Alexander, 1968 .

The Crystal and Molecular Structure of β-Adenosine-2′-β-uridine-5′-phosphoric Acid

K. Trueblood, E. Shefter, R. Sparks, 1964 .

Mapping Reaction Pathways from Crystallographic Data

E. Shefter, 1978 .

Conformations of highly hindered aryl ethers XXVI. Structural analysis by X-ray diffraction of 2,4-dinitronaphthyl-2′,6′-dimethylphenyl ether

V. Cody, E. Shefter, P. Lehmann F., 1976 .

Analysis of N-glycosyl bond length in crystal structures of nucleosides and nucleotides.

E. Shefter, A. Lo, T. Cochran, 1975, Journal of pharmaceutical sciences.

STRUCTURAL VARIATIONS IN CHOLINERGIC LIGANDS

E. Shefter, 1971 .

Acetylcholine and its thiolester and selenolester analogs: conformation, electron distribution, and biological activity.

H. Mautner, E. Shefter, 1969, Proceedings of the National Academy of Sciences of the United States of America.

Urinary calcium oxalate monohydrate crystals in ethylene glycol poisoning.

E. Shefter, D. Jacobsen, I. Åkesson, 1982, Scandinavian journal of clinical and laboratory investigation.

Conformation of a trans-diaxial decalin analog of acetylcholine.

E. Shefter, E. Smissman, 1971, Journal of pharmaceutical sciences.

Is there a Unique Conformation of Cholinergic Ligands responsible for Muscarinic Activity ?

D. Triggle, E. Shefter, 1970, Nature.

Prodrugs for improved oral nalbuphine bioavailability: inter-species differences in the disposition of nalbuphine and its acetylsalicylate and anthranilate esters

E. Shefter, B. Aungst, M. J. Myers, 1987 .

Hollow Fibers as an Oral Sustained-Release Delivery System

M. Hussain, E. Shefter, R. Diluccio, 2004, Pharmaceutical Research.

Drug-polyvinylpyrrolidone (PVP) dispersions. A differential scanning calorimetric study

E. Shefter, K. Cheng, 1980 .

Structural studies on molecular complexes. V. Crystal structures of sulfathiazole-sulfanilamide and sulfathiazole-theophylline complexes.

E. Shefter, P. Sackman, 1971, Journal of pharmaceutical sciences.

Oral and rectal nalbuphine bioavailability: first-pass metabolism in rats and dogs.

E. Shefter, B. Aungst, G. Lam, 1985, Biopharmaceutics & drug disposition.

Biological implications of molecular and crystal structures of sulfadimethoxine, sulfadoxine, and sulfisoxazole.

J. Blount, E. Shefter, T. Brennan, 1972, Journal of pharmaceutical sciences.

Thermoelastic wave fields in irradiated transparent materials containing optical discontinuities

E. Shefter, N. B. Erofeeva, 1980 .

Stereochemical studies on medicinal agents. 19. X-ray crystal structures of two (+/-)-allylprodine diastereomers. The role of the allyl group in conferring high stereoselectivity and potency at analgetic receptors.

P. Portoghese, E. Shefter, 1976, Journal of medicinal chemistry.

Sustained-release oral delivery of theophylline by use of polyvinyl alcohol and polyvinyl alcohol-methyl acrylate polymers.

M. Hussain, E. Shefter, R. Diluccio, 1994, Journal of pharmaceutical sciences.

Crystal structures of analgesics. Hydrochlorides of (minus)-isomethadone, alpha-methadol, and alpha-methadyl acetate.

E. Shefter, 1974, Journal of medicinal chemistry.

Polyvinyl Alcohol–Methyl Acrylate Copolymers as a Sustained-Release Oral Delivery System

M. Hussain, E. Shefter, R. Diluccio, 1989, Pharmaceutical Research.

Selective Precipitation of Interleukin-4 Using Hydrophobic Ion Pairing: A Method for Improved Analysis of Proteins Formulated with Large Excesses of Human Serum Albumin

M. Manning, J. Matsuura, E. Shefter, 1994, Pharmaceutical Research.

Dissolution behavior of 17β-estradiol (E2) from povidone coprecipitates. comparison with microcrystalline and macrocrystalline E2

P. Prasad, D. E. Resetarits, T. R. Bates, 1979 .

Thermal and photochemical rearrangements, and X-ray crystal structure of a 2-benzazocine derivative

A. Padwa, E. Shefter, E. Vega, 1972 .

Stereochemistry of nucleic acids and their constituents. 28. The crystal and molecular structure of N 2 -dimethylguanosine. A transfer ribonucleic acid rare nucleoside located at the junction of the anticodon and dihydrouridine arms.

M. Sundaralingam, E. Shefter, S. Rao, 1972, Journal of the American Chemical Society.

The molecular structure of the disulfide of the t-RNA constituent, 4-thiouridine.

E. Shefter, T. Kalman, 1968, Biochemical and biophysical research communications.

The crystal and molecular structure of a dinucleoside phosphate: β‐adenosine‐2'‐β‐uridine‐5'‐phosphoric acid

K. Trueblood, E. Shefter, R. Sparks, 1969 .

The crystal and molecular structure of 2,4-dithiouracil.

H. Mautner, E. Shefter, 1967, Journal of the American Chemical Society.

Phase transitions. I. Preliminary study of theophylline hydrate-anhydrate system.

E. Shefter, G. Kmack, 1967, Journal of pharmaceutical sciences.

Prodrugs for Improved Oral β-Estradiol Bioavailability

M. Hussain, E. Shefter, B. Aungst, 2004, Pharmaceutical Research.

X-Ray structure analysis of the disulphide from 1-methyl-5-mercaptouracil

E. Shefter, 1970 .

CRYSTAL STRUCTURES OF CALCIUM CHANNEL ANTAGONISTS: 2,6-DIMETHYL-3,5-DICARBOMETHOXY-4-(2-NITRO-, 3-CYANO-, 4-(DIMETHYLAMINO)-, AND 2,3,4,5,6-PENTAFLUOROPHENYL)-1,4-DIHYDROPYRIDINE

A. M. Triggle, D. Triggle, E. Shefter, 1981 .

More on the Pharmacist as a Drug Consultant Three Case Studies

A. Wertheimer, E. Shefter, R. Cooper, 1973 .

The crystal and molecular structure of a dinucleoside phosphate: beta-adenosine-2'-beta-uridine-5'-phosphoric acid.

K. Trueblood, E. Shefter, R. Sparks, 1969, Acta crystallographica. Section B: Structural crystallography and crystal chemistry.